amyloid P-IN-1 |
| Catalog No.GC33160 |
amyloÏde P-IN-1 est utilisé dans la recherche de maladies ou de troubles dans lesquels l'épuisement du composant amyloÏde P sérique (SAP), y compris l'amylose, la maladie d'Alzheimer, le diabète sucré de type 2 et l'arthrose.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1819986-22-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis.
[1]. PCT Int. Appl. (2015), WO 2015165833 A1 20151105. [2]. U.S. Pat. Appl. Publ. (2016), US 20160081983 A1 20160324.
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *